Blood clots kill and they make today's focus on cholesterol looks badly
misguided. Many natural approaches help and add Carnitine to that list. I
recently attended the Nevada Homeopathic and Integrative Medicine conference in
David Berg is an expert private consultant on blood coagulation issues.
His presentation there was videotaped will be available to purchase from the
association (President in Nevada is Dr Michael Gerber). David Berg made it
clear that his own prostate cancer went away using heparin based therapy. He
agrees with me that Coumadin is never the correct answer. He is very
impressed, however, with the benefits he sees with testing by reference labs he
refers his clients to and with treatment with natural products particularly
I reminded the attendees that EDTA MAKES HEPARIN WORK BY MOUTH, documented
in 1960, published in Nature and immediately patented by Riker. I have
used this to eliminate fatal heart attacks in all my patients for well over 20
years now. It is the basis for the product Beyond Chelation Improved, as
this took advantage of the $10 million in research by Dr Lester Morrison,
who found a HEPARIN-LIKE action from a particular seaweed based ingredient.
When I added ORAL EDTA to his institute formula, we immediately had a safe
oral anticoagulant and I use this as my alternative to Coumadin or Heparin
when I incorporate the essential fatty acids OMEGA 3 and PRIMROSE OIL to
the garlic, ginkgo and EDTA based formula.
Of course David Berg injected Lovenex for his cancer and others might use
other forms of Heparin by injection. But, the idea that fibrin is an issue
in delivering local oxygen to tissues where according to the Warburg
research, anaerobic metabolism supports cancer, we might expect that anything
that enhances local oxygen levels in tissues could be beneficial then for any
cancer. My experience in chelation and thermography has made me very aware
of the need to optimize tissue oxygen levels and the ability of chelation
to help that occur.
The attached article suggests that one more nutrient Carnitine may be of
further use in lowering fibrinogen and even C-reactive protein levels. We
know that inflammation sets the stage for hypercoagulability so this is
another useful nutrient to add to my long list of documented nutrients that are
useful in cancer like Vitamin C, Curcumin, Artemisinin, Quercetin alone or
as found with pancreatic enzymes in Wobenzym.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
L-Carnitine Plays a Role in Preventing Cardiovascular Disease.
Cardiovascular disease or heart disease is a class of diseases that
involve the heart or blood vessels (arteries and veins). There are several risk
factors for cardiovascular disease that are essentially immutable. These are
older age, male gender, and a family history of CVD. Additionally, three
major risk factors identified include cigarette smoking, dyslipidemia (high
cholesterol), and hypertension. Other identified factors associated with
increased risk for cardiovascular disease include physical inactivity, sleep
problems, diabetes mellitus, rheumatoid arthritis, obesity, excessive intake
of alcohol, thrombotic and fibrinolytic factors, elevated homocysteine
levels, certain infections and inflammation, exogenously administered
estrogens and androgens, certain psychosocial factors, increased fasting glucose.
and frequency of migraines. The synergism of the presence of multiple risk
factors must also be considered.
L-carnitine is an amino acid that is synthesized from the amino acids
lysine and methionine. Because it can be synthesized in the body, L-carnitine
is usually not considered to be an essential nutrient. However, it could be
classified as an essential nutrient for premature infants and other
individuals who are not able to synthesize it in sufficient amounts. In addition
to its use in clinical conditions, L-carnitine is used with exercise
programs to reduce muscle soreness.
A study published in the journal Renal Failure investigated the effects of
L-carnitine on plasma coagulation and anticoagulation. The researchers
enrolled thirty-six hemodialysis patients and the patients randomly received
either 1000 mg a day L-carnitine or a placebo for 12 weeks. Blood was
collected at the beginning of the trial and at the end to compare changes in
plasma activity. The results were the L-carnitine group experienced significant
reductions in serum C-reactive protein (marker for systemic inflammation)
and plasma fibrinogen (an inflammation-related coagulator) in comparison to
the placebo group. The authors stated "Therefore, l-carnitine may play an
effective role in preventing cardiovascular diseases in these patients."1
1 Hakeshzadeh F, Tabibi H, Ahmadinejad M, et al. Effects of L-Carnitine
supplement on plasma coagulation and anticoagulation factors in hemodialysis
patients. Ren Fail. 2010;32(9):1109-14.
[Non-text portions of this message have been removed]
Peacefulmind.com Sponsors Alternative Answers-
HEALING NATURALLY- Learn preventative and curative measure to take for many ailments at:
-To INVITE A FRIEND to our healing community, copy and paste this address in an email to them:
To ADD A LINK, RESOURCE, OR WEBSITE to Alternative Answers please Go to:
Community email addresses:
Post message: AlternativeAnswers@yahoogroups.com
List owner: AlternativeAnswersfirstname.lastname@example.org
Shortcut URL to this page: